November 08, 2023

Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. November 09, 2023

    Regeneron Hits Rival With Patent Suit Over Eye Med Generic

    Regeneron accused a South Korea-based rival of infringing a slew of patents covering the American biotech company's top eye medication in a new lawsuit filed in West Virginia, claiming that its Eylea product has exclusivity until mid-2024.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login